Ping An Biomedical Income Statement

Financials in millions CNY. Fiscal year is October - September.

Millions CNY. Fiscal year is Oct - Sep.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Revenue	34.15	87.62	82.56	114.55	99.52
Revenue Growth (YoY)	-61.03%	6.13%	-27.92%	15.10%	79.43%
Cost of Revenue	33.2	82.21	78.32	100.41	85.25
Gross Profit	0.95	5.42	4.24	14.14	14.27
Selling, General & Admin	6.31	5.3	3.6	3.52	3.76
Other Operating Expenses	9.34	0.12	0.03	-0.19	2.24
Total Operating Expenses	15.65	5.42	3.63	3.33	6
Operating Income	-14.7	-0	0.61	10.82	8.27
Interest Income	0.33	0	0.16	0.04	0
Interest Expense	-0.31	-0.71	-1.74	-1.57	-1.36
Other Non-Operating Income (Expense)	-0	0.02	1.01	0.33	0.91
Total Non-Operating Income (Expense)	0.02	-0.68	-0.57	-1.19	-0.45
Pretax Income	-14.68	-0.68	0.04	9.63	7.82
Provision for Income Taxes	-1.86	0.6	1.04	2.4	2.61
Net Income	-12.83	-1.28	-0.99	7.23	5.21
Net Income to Common	-12.83	-1.28	-0.99	7.23	5.21
Net Income Growth	-	-	-	38.61%	170.96%
Shares Outstanding (Basic)	18	18	18	18	18
Shares Outstanding (Diluted)	18	18	18	18	18
Shares Change (YoY)	2.66%	-	-	-	-
EPS (Basic)	-0.69	-0.07	-0.06	0.40	0.29
EPS (Diluted)	-0.69	-0.07	-0.06	0.40	0.29
EPS Growth	-	-	-	37.93%	172.94%
Free Cash Flow	-6.43	14.63	-6.08	21.06	-31.4
Free Cash Flow Per Share	-0.35	0.81	-0.34	1.17	-1.74
Gross Margin	2.78%	6.18%	5.14%	12.35%	14.34%
Operating Margin	-43.05%	-0.00%	0.74%	9.44%	8.31%
Profit Margin	-37.57%	-1.47%	-1.20%	6.31%	5.24%
FCF Margin	-18.82%	16.70%	-7.37%	18.39%	-31.55%
EBITDA	-14.7	0.01	0.65	10.84	8.29
EBITDA Margin	-43.04%	0.01%	0.78%	9.46%	8.33%
EBIT	-14.7	-0	0.61	10.82	8.27
EBIT Margin	-43.05%	-0.00%	0.74%	9.44%	8.31%
Effective Tax Rate	12.64%	-88.10%	2484.34%	24.92%	33.32%